Clene vs Cervomed
Cervomed is the larger business, with $4.0m of revenue in fiscal 2025 against $200,000 for Clene (20.0 times as much). Clene grew faster (-41.5% against -58.9%). Cervomed kept more of each dollar of sales as profit: a net margin of -673.1% against -13086.5%.
| Latest fiscal year | CleneCLNN, 2025 | CervomedCRVO, 2025 |
|---|---|---|
| Revenue | $200,000 | $4.0m |
| Revenue growth | -41.5% | -58.9% |
| Net income | −$26.2m | −$27.0m |
| Operating margin | — | -706.2% |
| Net margin | -13086.5% | -673.1% |
| Return on equity | — | -93.9% |
| Free cash flow | −$18.6m | −$23.4m |
| Cash | $5.2m | $8.2m |
| Total debt | $17.8m | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 79 | 15 |
| Market value | $47.9m | $21.0m |
| Price vs our value range | — | — |
| Moat score | 12 (Weak) | — |
| Insider trades, 12 months | 1 buys, 62 sales | 19 buys, 0 sales |